Entity Central Index Key
Right-of-use assets recognised as of acquisition date.
Other assets non-current and current recognised as of acquisition date.
Provisions non-current and current recognised as of acquisition date.
Trade payables recognised as of acquisition date.
Other liabilities non-current and current recognised as of acquisition date.
Assets recognized as of acquisition date.
Liabilities recognized as of acquisition date.
Shares issued, at fair value.
Bargain purchase gain on acquisition.
Other components of tax expense (income).
Government grants exempted from taxes.
Add back for trade tax purposes.
Non-tax effective bargain purchase.
Non recognition of tax effect on share based payment expenses.
Tax effective equity transaction costs.
Tax effect of nonrecognition of deferred taxes on tax losses and temporary differences.
Tax effect of tax credit.
Interest bearing loans and borrowings.
Current prepayments related to service contracts
Other current assets other.
Deferred expenses from insurance contracts.
Deferred expenses from contract manufacturing and contract research organizations.
Other deferred expenses.
Deferred expense current.
Deferred expense, non-current.
Current liabilities for employees benefits.
Other liabilities other.
Cover [Abstract]
Document Information [Table]
Document Information [Table]
Classes of share capital [axis]
Classes Of Share Capital [Axis]
Share capital [member]
Classes Of Share Capital [Member]
American Depositary Shares, each Representing one ordinary share.
American Depositary Shares, each Representing one ordinary share
American Depositary Shares Each Representing One Ordinary Share [Member]
Ordinary shares, no par value, with national amount attributable to each ordinary share of €1.
Ordinary shares, no par value, with national amount attributable to each ordinary share of ?1
Ordinary Shares No Par Value With National Amount Attributable To Each Ordinary Share Of One [Member]
Entity Addresses, Address Type
Entity Addresses Address Type [Axis]
Address Type
Address Type [Domain]
Business Contact
Business Contact [Member]
Document Information [Line Items]
Document Information [Line Items]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Current Fiscal Year End Date
Document Fiscal Period Focus
Document Fiscal Period Focus
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Document Registration Statement
Document Registration Statement
Document Shell Company Report
Document Shell Company Report
Entity Current Reporting Status
Entity Current Reporting Status
Entity Voluntary Filers
Entity Voluntary Filers
Entity Interactive Data Current
Entity Interactive Data Current
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Entity Filer Category
Entity Filer Category
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Entity Shell Company
Entity Shell Company
Entity Emerging Growth Company
Entity Emerging Growth Company
Trading Symbol
Trading Symbol
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
No Trading Symbol Flag
No Trading Symbol Flag
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity File Number
Entity File Number
Contact Personnel Name
Contact Personnel Name
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, City or Town
Entity Address City Or Town
Entity Address, Country
Entity Address Country
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Contact Personnel Email Address
Contact Personnel Email Address
Entity Address, City or Town
Document Accounting Standard
Document Accounting Standard
Statement Of Financial Position [Abstract]
Assets
Assets [Abstract]
Non-current assets
Noncurrent Assets [Abstract]
Intangible assets
Intangible Assets And Goodwill
Property, plant and equipment
Property Plant And Equipment
Right-of-use assets
Rightofuse Assets
Other assets
Other Noncurrent Assets
Deferred tax assets
Deferred Tax Assets
Total non-current assets
Noncurrent Assets
Current assets
Current Assets [Abstract]
Inventories
Inventories
Trade receivables
Current Trade Receivables
Other financial assets
Other Current Financial Assets
Other assets
Other Current Assets
Income tax assets
Current Tax Assets Current
Deferred expenses
Deferred Expense Current
Cash and cash equivalents
Cash And Cash Equivalents
Total current assets
Current Assets
Total assets
Assets
Equity and liabilities
Equity And Liabilities [Abstract]
Equity
Equity [Abstract]
Share capital
Issued Capital
Capital reserve
Capital Reserve
Treasury shares
Treasury Shares
Accumulated losses
Accumulated Other Comprehensive Income
Other reserves
Other Reserves
Total equity
Equity
Non-current liabilities
Noncurrent Liabilities [Abstract]
Interest-bearing loans and borrowings
Longterm Borrowings
Other financial liabilities
Other Noncurrent Financial Liabilities
Provisions
Noncurrent Provisions
Contract liabilities
Noncurrent Contract Liabilities
Other liabilities
Other Noncurrent Liabilities
Deferred tax liabilities
Deferred Tax Liabilities
Total non-current liabilities
Noncurrent Liabilities
Current liabilities
Current Liabilities [Abstract]
Interest-bearing loans and borrowings
Shortterm Borrowings
Trade payables
Trade And Other Current Payables To Trade Suppliers
Other financial liabilities
Other Current Financial Liabilities
Government grants
Current Government Grants
Tax provisions
Current Tax Liabilities Current
Other provisions
Other Shortterm Provisions
Contract liabilities
Current Contract Liabilities
Other liabilities
Other Current Liabilities
Total current liabilities
Current Liabilities
Total liabilities
Liabilities
Total equity and liabilities
Equity And Liabilities
Profit Loss [Abstract]
Income statement.
Income statement.
Income Statement [Table]
Income Statement [Table]
Products and services [axis]
Products And Services [Axis]
Products and services [member]
Products And Services [Member]
Research and development.
Research & Development
Research And Development [Member]
Commercial.
Commercial
Commercial [Member]
Income Statement [Line Items]
Income Statement [Line Items]
Revenues
Revenue [Abstract]
Total revenues
Revenue From Contracts With Customers
Cost of sales
Cost Of Sales
Research and development expenses
Research And Development Expense
Sales and marketing expenses
Sales And Marketing Expense
General and administrative expenses
General And Administrative Expense
Other operating expenses
Miscellaneous Other Operating Expense
Other operating income
Miscellaneous Other Operating Income
Operating loss
Profit Loss From Operating Activities
Finance income
Finance Income
Finance expenses
Finance Costs
Interest expenses related to lease liabilities
Interest Expense On Lease Liabilities
Share of loss of equity method investees
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method
Loss before tax
Profit Loss Before Tax
Income taxes
Income Tax Expense Continuing Operations
Profit / (Loss) for the period
Profit Loss
Attributable to:
Profit Loss Attributable To [Abstract]
Equity holders of the parent
Profit Loss Attributable To Owners Of Parent
Non-controlling interests
Profit Loss Attributable To Noncontrolling Interests
Earnings per share
Earnings Per Share [Abstract]
Basic and diluted, profit / (loss) for the period attributable to ordinary equity holders of the parent
Basic And Diluted Earnings Loss Per Share
Stock split conversion ratio.
Stock split ratio
Stock Split Conversion Ratio
Statement Of Comprehensive Income [Abstract]
Profit / (Loss) for the period
Other comprehensive income / (loss)
Other Comprehensive Income [Abstract]
Other comprehensive income / (loss) that may be reclassified to profit or loss in subsequent periods, net of tax
Components Of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax [Abstract]
Exchange differences on translation of foreign operations
Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Net other comprehensive income / (loss) that may be reclassified to profit or loss in subsequent periods
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax
Other comprehensive loss that will not be reclassified to profit or loss in subsequent periods, net of tax
Components Of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax [Abstract]
Remeasurement loss on defined benefit plans
Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans
Net other comprehensive loss that will not be reclassified to profit or loss in subsequent periods
Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax
Other comprehensive income / (loss) for the period, net of tax
Other Comprehensive Income
Comprehensive income / (loss) for the period, net of tax
Comprehensive Income
Attributable to:
Comprehensive Income Attributable To [Abstract]
Equity holders of the parent
Comprehensive Income Attributable To Owners Of Parent
Non-controlling interests
Comprehensive Income Attributable To Noncontrolling Interests
Issuance of share capital.
Increase (decrease) through settlement of sharebased payment plan.
Increase decrease through initial public offering.
Increase decrease through acquisition of noncontrolling interests.
Statement Of Changes In Equity [Abstract]
Statement Of Changes In Equity [Table]
Statement Of Changes In Equity [Table]
Components of equity [axis]
Components Of Equity [Axis]
Equity [member]
Equity [Member]
Share Capital
Issued Capital [Member]
Capital Reserve
Capital Reserve [Member]
Treasury Shares
Treasury Shares [Member]
Accumulated Losses
Accumulated Other Comprehensive Income [Member]
Other Reserves
Other Reserves [Member]
Foreign currency translation reserve.
Foreign Currency Translation Reserve
Foreign Currency Translation Reserve [Member]
Total
Equity Attributable To Owners Of Parent [Member]
Non-controlling Interest
Noncontrolling Interests [Member]
Capital increase series B.
Series B
Capital Increase Series B [Member]
Statement Of Changes In Equity [Line Items]
Statement Of Changes In Equity [Line Items]
Beginning balance
Profit / (Loss) for the period
Other comprehensive income / (loss)
Issuance of share capital
Issuance Of Share Capital
Capital increase initial public offering (referred to as IPO)
Increase Decrease Through Initial Public Offering
Acquisition of non-controlling interest
Increase Decrease Through Acquisition Of Noncontrolling Interests
Transaction costs
Share Issue Related Cost
Share based payments
Increase Decrease Through Sharebased Payment Transactions
Settlement of share-based payment plan
Increase Decrease Through Settlement Of Sharebased Payment Plan
Ending balance
Adjustments for interest on lease liability.
Adjustments for movements in government grants.
Adjustments for increase decrease in trade account receivable and contract assets.
Adjustments for increase (decrease) in trade payables, other liabilities, contract liabilities and provisions.
Purchase of intangible assets and right of use assets.
Working capital adjustments abstract.
Statement Of Cash Flows [Abstract]
Operating activities
Cash Flows From Used In Operating Activities [Abstract]
Income taxes
Loss before tax
Adjustments to reconcile loss before tax to net cash flows:
Adjustments For Reconcile Profit Loss [Abstract]
Depreciation and amortization of property, plant, equipment and intangible assets
Adjustments For Depreciation And Amortisation Expense
Share-based payment expense
Adjustments For Sharebased Payments
Net foreign exchange differences
Adjustments For Unrealised Foreign Exchange Losses Gains
(Gain) / Loss on disposal of property, plant and equipment
Adjustments For Gain Loss On Disposals Property Plant And Equipment
Finance income
Adjustments For Finance Income
Interest on lease liability
Adjustments For Interest On Lease Liability
Finance expense
Adjustments For Finance Costs
Movements in government grants
Adjustments For Movements In Government Grants
Share of loss of an associate and a joint venture
Other non-cash income
Other Adjustments For Noncash Items
Working capital adjustments:
Working Capital Adjustments [Abstract]
Decrease / (Increase) in trade receivable and contract assets
Adjustments For Increase Decrease In Trade Account Receivable And Contract Assets
Decrease / (Increase) in inventories
Adjustments For Decrease Increase In Inventories
(Decrease) / Increase in trade payables, other liabilities, contract liabilities and provisions
Adjustments For Increase Decrease In Trade Payables Other Liabilities Contract Liabilities And Provisions
Interest received
Interest Received Classified As Operating Activities
Interest paid
Interest Paid Classified As Operating Activities
Income tax received (paid), net
Income Taxes Paid Refund Classified As Operating Activities
Net cash flows used in operating activities
Cash Flows From Used In Operating Activities
Investing activities
Cash Flows From Used In Investing Activities [Abstract]
Purchase of property, plant and equipment
Purchase Of Property Plant And Equipment Classified As Investing Activities
Proceeds from sale of property, plant and equipment
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities
Purchase of intangibles assets and right-of-use assets
Purchase Of Intangible Assets And Right Of Use Assets
Acquisition of subsidiaries and businesses, net of cash acquired
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities
Net cash flows used in investing activities
Cash Flows From Used In Investing Activities
Financing activities
Cash Flows From Used In Financing Activities [Abstract]
Proceeds from issuance of share capital, net of costs
Proceeds From Issuing Shares
Proceeds from loans and borrowings
Proceeds From Borrowings Classified As Financing Activities
Repayment of loans and borrowings
Repayments Of Borrowings Classified As Financing Activities
Payments related to lease liabilities
Payments Of Lease Liabilities Classified As Financing Activities
Net cash flows from financing activities
Cash Flows From Used In Financing Activities
Net increase in cash and cash equivalents
Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Change in cash and cash equivalents resulting from exchange rate differences
Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Cash and cash equivalents at January 1
Cash and cash equivalents at December 31
Disclosure of corporate information explanatory.
Disclosure of corporate information explanatory.
Disclosure Of Corporate Information Explanatory [Abstract]
Corporate information
Disclosure Of Corporate Information Explanatory
Disclosure of summary of significant accounting policies abstract.
Disclosure Of Summary Of Significant Accounting Policies [Abstract]
Significant Accounting Policies
Disclosure Of Summary Of Significant Accounting Policies Explanatory
Disclosure of accounting judgements and estimates.
Disclosure Of Accounting Judgements And Estimates [Abstract]
Significant Accounting Judgments, Estimates and Assumptions
Disclosure Of Accounting Judgements And Estimates Explanatory
Disclosure Of Significant Investments In Subsidiaries [Abstract]
Group information
Disclosure Of Composition Of Group Explanatory
Disclosure Of Business Combinations [Abstract]
Business Combinations
Disclosure Of Business Combinations Explanatory
Disclosure of revenue from contracts with customers.
Disclosure Of Revenue From Contracts With Customers [Abstract]
Revenue from Contracts with Customers
Disclosure Of Revenue From Contracts With Customers Explanatory
The detailed information about income and expenses.
Analysis Of Income And Expense [Abstract]
Income and Expenses
Disclosure Of Income And Expenses Explanatory
Major Components Of Tax Expense Income [Abstract]
Income Tax
Disclosure Of Income Tax Explanatory
Earnings per share
Disclosure Of Earnings Per Share Explanatory
Disclosure Of Property Plant And Equipment [Abstract]
Property, Plant and Equipment
Disclosure Of Property Plant And Equipment Explanatory
Disclosure Of Intangible Assets [Abstract]
Intangible Assets
Disclosure Of Intangible Assets Explanatory
Disclosure Of Financial Instruments [Abstract]
Financial Assets and Financial Liabilities
Disclosure Of Offsetting Of Financial Assets And Financial Liabilities Explanatory
Classes Of Inventories [Abstract]
Inventories
Disclosure Of Inventories Explanatory
Miscellaneous Current Assets [Abstract]
Other Assets
Disclosure Of Other Current Assets Explanatory
Disclosure of deferred expenses explanatory.
Disclosure of deferred expenses.
Disclosure Of Deferred Expenses [Abstract]
Deferred Expenses
Disclosure Of Deferred Expenses Explanatory
Disclosure Of Classes Of Share Capital [Abstract]
Issued Capital and Reserves
Disclosure Of Share Capital Reserves And Other Equity Interest Explanatory
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Abstract]
Share-based payments
Disclosure Of Sharebased Payment Arrangements Explanatory
Miscellaneous Current Liabilities [Abstract]
Other Liabilities
Disclosure Of Other Liabilities Explanatory
Presentation Of Leases For Lessee [Abstract]
Leases
Disclosure Of Leases Explanatory
Disclosure Of Information About Defined Benefit Plans [Abstract]
Pensions
Disclosure Of Employee Benefits Explanatory
Disclosure Of Transactions Between Related Parties [Abstract]
Related Party Disclosures
Disclosure Of Related Party Explanatory
Disclosure of events after reporting period.
Disclosure Of Events After Reporting Period [Abstract]
Events After the Reporting Period
Disclosure Of Events After Reporting Period Explanatory
Basis of Preparation
Disclosure Of Basis Of Preparation Of Financial Statements Explanatory
Basis of Consolidation
Disclosure Of Basis Of Consolidation Explanatory
Business combinations and Goodwill
Description Of Accounting Policy For Business Combinations And Goodwill Explanatory
Description of accounting policy for assets and liabilities explanatory.
Current versus Non-Current Classifications
Description Of Accounting Policy For Assets And Liabilities Explanatory
Fair Value Measurement
Description Of Accounting Policy For Fair Value Measurement Explanatory
Description of accounting policy for revenue from contracts with customers explanatory.
Revenue from Contracts with Customers
Description Of Accounting Policy For Revenue From Contracts With Customers Explanatory
Government Grants
Description Of Accounting Policy For Government Grants
Taxes
Description Of Accounting Policy For Income Tax Explanatory
Foreign Currencies
Description Of Accounting Policy For Foreign Currency Translation Explanatory
Property, Plant and Equipment
Description Of Accounting Policy For Property Plant And Equipment Explanatory
Leases
Description Of Accounting Policy For Leases Explanatory
Intangible Assets
Description Of Accounting Policy For Intangible Assets And Goodwill Explanatory
Financial Instruments – Initial Recognition and Subsequent Measurement
Description Of Accounting Policy For Financial Instruments Explanatory
Inventories
Description Of Accounting Policy For Measuring Inventories
Impairment of Non-Financial Assets
Description Of Accounting Policy For Impairment Of Nonfinancial Assets Explanatory
Cash and Cash Equivalents
Description Of Accounting Policy To Determine Components Of Cash And Cash Equivalents
Pension
Description Of Accounting Policy For Employee Benefits Explanatory
Provisions
Description Of Accounting Policy For Provisions Explanatory
Share-Based Payments
Description Of Accounting Policy For Sharebased Payment Transactions Explanatory
Description of accounting policy for initial application of standards explanatory.
Standards Applied for the First Time
Description Of Accounting Policy For Initial Application Of Standards Explanatory
Description of accounting policy for standard issued but not yet effective explanatory.
Standard Issued but not yet Effective
Description Of Accounting Policy For Standard Issued But Not Yet Effective Explanatory
Disclosure of property plant and equipment estimated useful lives explanatory.
Useful Lives Applied to the Group's Property, Plant and Equipment
Disclosure Of Property Plant And Equipment Estimated Useful Lives Explanatory
Disclosure of right of use assets estimated useful lives explanatory.
Useful Lives Applied to the Group's Right-of-use Assets
Disclosure Of Right Of Use Assets Estimated Useful Lives Explanatory
Disclosure of intangible assets useful life explanatory.
Useful Lives Applied to the Group's Intangible Assets
Disclosure Of Intangible Assets Useful Life Explanatory
Disclosure of detailed information about provisional sales figures for territories.
Schedule of Provisional Sales Figures for Territories
Disclosure Of Detailed Information About Provisional Sales Figures For Territories Explanatory
Summary of Information about Subsidiaries
Disclosure Of Significant Investments In Subsidiaries Explanatory
Disclosure of significant investments by parent company.
Summary of Information about Parent Company
Disclosure Of Significant Investments By Parent Company Explanatory
Disclosure of entity with significant influence over the group.
Summary of Information about Entity with Significant Influence Over Group
Disclosure Of Entity With Significant Influence Over Group Explanatory
Disclosure Of Business Combinations [Table]
Disclosure Of Business Combinations [Table]
Business combinations [axis]
Business Combinations [Axis]
Entity's total for business combinations [member]
Entitys Total For Business Combinations [Member]
Lipocalyx GmbH.
Lipocalyx GmbH
Lipocalyx Gmb H [Member]
BioNTech US Inc.
BioNTech US Inc.
Bio N Tech U S Inc [Member]
BioNTech Manufacturing Marburg GmbH.
BioNTech Manufacturing Marburg GmbH
Bio N Tech Manufacturing Marburg Gmb H [Member]
Disclosure Of Business Combinations [Line Items]
Disclosure Of Business Combinations [Line Items]
Summary of Fair Values of Identifiable Net Assets
Disclosure Of Detailed Information About Business Combinations Explanatory
Summary of Reconciliation of Goodwill
Disclosure Of Reconciliation Of Changes In Goodwill Explanatory
Summary of Disaggregation of Revenues from Contracts with Customers
Disclosure Of Disaggregation Of Revenue From Contracts With Customers Explanatory
Disclosure of contract balances from contracts with customers explanatory.
Summary of Contract Balances
Disclosure Of Contract Balances From Contracts With Customers Explanatory
Revenue recognized in the reporting period, which has been included in contract liabilities at the beginning of the year.
Summary of Revenue Recognized
Disclosure Of Recognition Of Revenue Explanatory
Summary of Contract Liabilities Allocated to Remaining Performance Obligations (Unsatisfied or Partially Unsatisfied)
Disclosure Of Performance Obligations Explanatory
Cost of Sales
Disclosure Of Cost Of Sales Explanatory
Research and Development Expenses
Disclosure Of Research And Development Expense Explanatory
Disclosure of sales and marketing expenses.
Sales and Marketing Expenses
Disclosure Of Sales And Marketing Expenses Explanatory
General and Administrative Expenses
Disclosure Of General And Administrative Expense Explanatory
Other Operating Income
Disclosure Of Other Operating Income Explanatory
Disclosure of changes regarding government grants.
Changes Regarding Government Grants
Disclosure Of Changes Regarding Government Grants Explanatory
Finance Income
Disclosure Of Finance Income Explanatory
Finance Expenses
Disclosure Of Finance Cost Explanatory
Disclosure of detailed information about employee benefits expense.
Employee Benefits Expense
Disclosure Of Detailed Information About Employee Benefits Expense Explanatory
Disclosure of current and deferred tax expense explanatory.
Summary of Current and Deferred Tax Expense
Disclosure Of Current And Deferred Tax Expense Explanatory
Disclosure of reconciliation of expected income tax benefit to actual income tax benefit explanatory.
Summary of Reconciliation of Expected Income Tax Benefit to Actual Income Tax Benefit
Disclosure Of Reconciliation Of Expected Income Tax Benefit To Actual Income Tax Benefit Explanatory
Summary of Deferred Taxes
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits Explanatory
Disclosure of accumulated tax losses.
Summary of Accumulated Tax Losses
Disclosure Of Accumulated Tax Losses Explanatory
Summary of Income and Share Data Used in the Basic and Diluted EPS Calculations
Earnings Per Share Explanatory
Summary of Property Plant and Equipment
Disclosure Of Detailed Information About Property Plant And Equipment Explanatory
Summary of Detailed Information About Intangible Assets
Disclosure Of Detailed Information About Intangible Assets Explanatory
Disclosure of goodwill acquired in respective business combinations.
Summary of Goodwill Recognized
Disclosure Of Goodwill Acquired In Respective Business Combinations Explanatory
Summary of Cash and Cash Equivalents
Disclosure Of Cash And Cash Equivalents Explanatory
Summary of Financial Assets at Amortized Cost
Disclosure Of Financial Assets Explanatory
Summary of Financial Liabilities at Amortized Cost
Disclosure Of Financial Liabilities Explanatory
Disclosure of foreign currency risk.
Summary of Carrying Amount of Monetary Assets
Disclosure Of Foreign Currency Risk Explanatory
Summary of Effect of Changes in Foreign Exchange Rates
Disclosure Of Effect Of Changes In Foreign Exchange Rates Explanatory
Summary of Changes in Liabilities Arising From Financing Activities
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities Explanatory
Disclosure of classes of inventories.
Summary of Inventories
Disclosure Of Classes Of Inventories Explanatory
Disclosure of detailed information about other assets explanatory.
Summary of Other Assets
Disclosure Of Detailed Information About Other Assets Explanatory
Summary of Deferred Expenses
Disclosure Of Expenses Explanatory
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table]
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table]
Types of share-based payment arrangements [axis]
Types Of Sharebased Payment Arrangements [Axis]
Share-based payment arrangements [member]
Sharebased Payment Arrangements [Member]
Employee equity plan.
Employee Equity Plan
Employee Equity Plan [Member]
Management board grant.
Management Board Grant
Management Board Grant [Member]
Chief executive officer grant.
Chief Executive Officer Grant
Chief Executive Officer Grant [Member]
Employee stock ownership plan.
Employee Stock Ownership Plan
Employee Stock Ownership Plan [Member]
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Schedule of Number and Share Price of Restricted Stock Units
Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments Explanatory
Schedule of Expense Recognized for Employee Services Received
Explanation Of Effect Of Sharebased Payments On Profit Or Loss
Schedule of Number and Weighted-Average Exercise Price of Share Options
Disclosure Of Number And Weighted Average Exercise Prices Of Share Options Explanatory
Summary of Inputs Used in Measurement of Fair Value at Grant Date
Disclosure Of Indirect Measurement Of Fair Value Of Goods Or Services Received Share Options Granted During Period Explanatory
Disclosure of Detailed Information About Other Liabilities Explanatory
Summary of Other Liabilities
Disclosure Of Detailed Information About Other Liabilities Explanatory
Summary of Right-of-Use Assets within Consolidated Statements of Financial Position
Disclosure Of Quantitative Information About Rightofuse Assets Explanatory
Disclosure of detailed information about lease liabilities.
Summary of Lease Liability Included in Interest-Bearing Loans and Borrowings
Disclosure Of Detailed Information About Lease Liabilities Explanatory
Disclosure of detailed information about lease expense recognized instatement of operations.
Summary of Amounts Recognized in Consolidated Statement of Operations
Disclosure Of Detailed Information About Lease Expense Recognized Instatement Of Operations Explanatory
Summary of Defined Benefit Obligation Recognized in Non-current Provisions
Disclosure Of Defined Benefit Plans Explanatory
Disclosure of detailed information about net benefit expense recognized in statement of profit or loss.
Summary of Components of Net Benefit Expense Recognized in Statement of Profit or Loss
Disclosure Of Detailed Information About Net Benefit Expense Recognized In Statement Of Profit Or Loss Explanatory
Disclosure of detailed information about remeasurements recognized in other comprehensive income.
Summary of Components of Remeasurements Recognized in Other Comprehensive Income
Disclosure Of Detailed Information About Remeasurements Recognized In Other Comprehensive Income Explanatory
Schedule of Changes to Defined Benefit Obligation
Disclosure Of Net Defined Benefit Liability Asset Explanatory
Schedule of Principal Assumptions used in Determining Defined Benefit Obligations
Disclosure Of Analysis Of Present Value Of Defined Benefit Obligation That Distinguishes Nature Characteristics And Risks Explanatory
Schedule of Quantitative Sensitivity Analysis
Disclosure Of Sensitivity Analysis For Actuarial Assumptions Explanatory
Disclosure of detailed information about expected payments or contributions to defined benefit plan.
Schedule of Expected Payments or Contributions to Plans in Future Years
Disclosure Of Detailed Information About Expected Payments Or Contributions To Defined Benefit Plan Explanatory
Summary of Compensation of Key Management Personnel
Disclosure Of Information About Key Management Personnel Explanatory
Summary of Transactions Between Other Related Parties
Disclosure Of Transactions Between Related Parties Explanatory
Number of new real estate entities founded.
Disclosure of corporate information.
Disclosure of corporate information.
Disclosure Of Corporate Information [Table]
Disclosure Of Corporate Information [Table]
Geographical areas [axis]
Geographical Areas [Axis]
Geographical areas [member]
Geographical Areas [Member]
Germany
GERMANY
Disclosure Of Corporate Information [Line Items]
Disclosure Of Corporate Information [Line Items]
Number of new real estate entities founded
Number Of New Real Estate Entities Founded
Number of operation segments.
Number of reporting segments.
Minimum number of countries in which COVID-19 vaccine authorized or approved for emergency or temporary use or granted conditional marketing authorization.
Number of operation segments
Number Of Operation Segments
Number of reporting segment
Number Of Reporting Segments
Minimum number of countries in which COVID-19 vaccine was authorized or approved for emergency or temporary use or granted conditional marketing authorization
Minimum Number Of Countries In Which C O V I D19 Vaccine Authorized Or Approved For Emergency Or Temporary Use Or Granted Conditional Marketing Authorization
Payment terms in contracts with customers
Description Of Significant Payment Terms In Contracts With Customers
Disclosure Of Property Plant And Equipment [Table]
Disclosure Of Property Plant And Equipment [Table]
Classes of property, plant and equipment [axis]
Classes Of Property Plant And Equipment [Axis]
Property, plant and equipment [member]
Property Plant And Equipment [Member]
Buildings
Buildings [Member]
Equipment, tools and installations.
Equipment, Tools and Installations
Equipment Tools And Installations [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Minimum
Bottom Of Range [Member]
Maximum
Top Of Range [Member]
Disclosure Of Property Plant And Equipment [Line Items]
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment, Useful life (Years)
Useful Life Measured As Period Of Time Property Plant And Equipment
Useful life measured as period of time right-of-use-assets.
Disclosure Of Quantitative Information About Leases For Lessee [Abstract]
Disclosure Of Quantitative Information About Rightofuse Assets [Table]
Disclosure Of Quantitative Information About Rightofuse Assets [Table]
Classes of assets [axis]
Classes Of Assets [Axis]
Assets [member]
Classes Of Assets [Member]
Production facilities.
Production Facilities
Production Facilities [Member]
Automobiles
Vehicles [Member]
Disclosure Of Quantitative Information About Rightofuse Assets [Line Items]
Disclosure Of Quantitative Information About Rightofuse Assets [Line Items]
Right-of-use assets, Useful life (Years)
Useful Life Measured As Period Of Time Right Of Use Assets
Disclosure Of Intangible Assets [Table]
Disclosure Of Intangible Assets [Table]
Classes of intangible assets other than goodwill [axis]
Classes Of Intangible Assets Other Than Goodwill [Axis]
Intangible assets other than goodwill [member]
Intangible Assets Other Than Goodwill [Member]
Intellectual property rights.
Intellectual Property Rights
Intellectual Property Rights [Member]
Licenses
Licences [Member]
Software
Computer Software [Member]
Disclosure Of Intangible Assets [Line Items]
Disclosure Of Intangible Assets [Line Items]
Intangible assets, Useful life (Years)
Useful Life Measured As Period Of Time Intangible Assets Other Than Goodwill
Estimated milestone payment to be received at contract inception.
Significant accounting judgments, estimates and assumptions.
Significant Accounting Judgments Estimates And Assumptions [Abstract]
Estimated milestone payment to be received
Estimated Milestone Payment To Be Received At Contract Inception
Significant accounting judgments estimates and assumptions.
Significant accounting judgments estimates and assumptions.
Significant Accounting Judgments Estimates And Assumptions [Table]
Significant Accounting Judgments Estimates And Assumptions [Table]
German Territory
U.S. Territory
UNITED STATES
Outside US.
Territories Outside the U.S.
Outside U S [Member]
Sales channels [axis]
Sales Channels [Axis]
Sales channels [member]
Sales Channels [Member]
Direct Product Sales to BioNTech Customers
Goods Sold Directly To Consumers [Member]
Collaboration agreement.
Share of Collaboration Partner's Gross Profit
Collaboration Agreement [Member]
Significant Accounting Judgments Estimates And Assumptions [Line Items]
Significant Accounting Judgments Estimates And Assumptions [Line Items]
Revenue from contracts with customers
Disclosure Of Significant Investments In Subsidiaries [Table]
Disclosure Of Significant Investments In Subsidiaries [Table]
Subsidiaries [axis]
Significant Investments In Subsidiaries [Axis]
Entity's total for subsidiaries [member]
Entitys Total For Subsidiaries [Member]
BioNTech RNA Pharmaceuticals GmbH.
BioNTech RNA Pharmaceuticals GmbH
Bio N Tech R N A Pharmaceuticals Gmb H [Member]
BioNTech Delivery Technologies GmbH.
BioNTech Delivery Technologies GmbH
Bio N Tech Delivery Technologies Gmb H [Member]
BioNTech Diagnostics GmbH.
BioNTech Diagnostics GmbH
Bio N Tech Diagnostics Gmb H [Member]
BioNTech Europe GmbH.
BioNTech Europe GmbH (previously BioNTech Small Molecules GmbH)
Bio N Tech Europe Gmb H [Member]
BioNTech Manufacturing GmbH.
BioNTech Manufacturing GmbH (previously BioNTech IVAC GmbH)
Bio N Tech Manufacturing Gmb H [Member]
BioNTech Austria Beteiligungen GmbH.
BioNTech Austria Beteiligungen GmbH
Bio N Tech Austria Beteiligungen Gmb H [Member]
BioNTech Innovative Manufacturing Services GmbH
BioNTech Innovative Manufacturing Services GmbH
Bio N Tech Innovative Manufacturing Services Gmb H [Member]
ReSano GmbH.
ReSano GmbH (previously reBOOST Management GmbH)
Re Sano Gmb H [Member]
JPT Peptide Technologies GmbH
JPT Peptide Technologies GmbH
J P T Peptide Technologies Gmb H [Member]
JPT Peptide Technologies Inc.
JPT Peptide Technologies Inc.
J P T Peptide Technologies Inc [Member]
BioNTech USA Holding LLC.
BioNTech USA Holding LLC
Bio N Tech U S A Holding L L C [Member]
BioNTech Research and Development Inc.
BioNTech Research and Development Inc.
Bio N Tech Research And Development Inc [Member]
BioNTech Cell & Gene Therapies GmbH.
BioNTech Cell & Gene Therapies GmbH
Bio N Tech Cell And Gene Therapies Gmb H [Member]
BioNTech Pharmaceuticals Asia Pacific Pte. Ltd.
BioNTech Pharmaceuticals Asia Pacific Pte. Ltd
Bio N Tech Pharmaceuticals Asia Pacific Pte Ltd [Member]
BioNTech Real Estate Verwaltungs GmbH.
BioNTech Real Estate Verwaltungs GmbH
Bio N Tech Real Estate Verwaltungs Gmb H [Member]
BioNTech UK Limited.
BioNTech UK Limited
Bio N Tech U K Limited [Member]
BioNTech Real Estate GmbH & Co. KG.
BioNTech Real Estate GmbH & Co. KG
Bio N Tech Real Estate Gmb H And Co K G [Member]
BioNTech Real Estate Holding GmbH.
BioNTech Real Estate Holding GmbH
Bio N Tech Real Estate Holding Gmb H [Member]
BioNTech Real Estate an der Goldgrube GmbH & Co. KG.
BioNTech Real Estate An der Goldgrube GmbH & Co. KG
Bio N Tech Real Estate Der Goldgrube Gmb H Co K G [Member]
BioNTech Real Estate Haus Vier GmbH & Co. KG.
BioNTech Real Estate Haus Vier GmbH & Co. KG
Bio N Tech Real Estate Haus Vier Gmb H Co K G [Member]
BioNTech Real Estate Adam Opel Straße GmbH & Co. KG.
BioNTech Real Estate Adam Opel Straße GmbH & Co. KG
Bio N Tech Real Estate Adam Opel Strae Gmb H Co K G [Member]
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Country of incorporation
Country Of Incorporation Or Residence Of Subsidiary
Registered office
Principal Place Of Business Of Subsidiary
% equity interest
Proportion Of Ownership Interest In Subsidiary
Number of entities acquired during the period.
Number of new entities.
Neon Therapeutics Inc and Novartis Manufacturing GmbH.
Neon Therapeutics Inc. (subsequently renamed BioNTech US Inc.) and Novartis Manufacturing GmbH (subsequently renamed BioNTech Manufacturing Marburg GmbH)
Neon Therapeutics Inc And Novartis Manufacturing Gmb H [Member]
BioNTech USA Holding, LLC and BioNTech Research & Development, Inc.
BioNTech USA Holding, LLC and BioNTech Research & Development, Inc.
Bio N Tech U S A Holding L L C And Bio N Tech Research And Development Inc [Member]
Categories of related parties [axis]
Categories Of Related Parties [Axis]
Entity's total for related parties [member]
Entitys Total For Related Parties [Member]
Number of entities acquired during the period
Number Of Entities Acquired During Period
Number of entities
Number Of New Entities
Ownership
Ownership [Axis]
Ownership
Ownership [Domain]
BioNTech.
BioNTech
Bio N Tech [Member]
AT Impf GmbH, parent company of BioNTech.
AT Impf GmbH
A T Impf Gmb H [Member]
Ownership of ordinary shares in BioNTech
Medine GmbH.
Medine GmbH
Medine Gmb H [Member]
Items of contingent liabilities [axis]
Items Of Contingent Liabilities [Axis]
Items of contingent liabilities [member]
Items Of Contingent Liabilities [Member]
Phase 1 clinical trial.
Phase 1 Clinical Trial
Phase One Clinical Trial [Member]
Phase 2 clinical trial.
Phase 2 Clinical Trial
Phase Two Clinical Trial [Member]
In-process R&D
Intangible Assets Under Development [Member]
Name of acquiree
Name Of Acquiree
Cash consideration
Cash Transferred
Date of acquisition
Date Of Acquisition2013
Estimated contingent consideration
Contingent Consideration Recognised As Of Acquisition Date
Identifiable assets acquired (liabilities assumed) and goodwill.
Identifiable assets acquired (liabilities assumed) and goodwill net of bargain purchase.
Assets
Amounts Recognised As Of Acquisition Date For Each Major Class Of Assets Acquired And Liabilities Assumed [Abstract]
Goodwill
Goodwill Recognised As Of Acquisition Date
Intangible assets
Identifiable Intangible Assets Recognised As Of Acquisition Date
Property, plant and equipment
Property Plant And Equipment Recognised As Of Acquisition Date
Right-of-use assets
Right Of Use Assets Recognised As Of Acquisition Date
Inventories
Inventory Recognised As Of Acquisition Date
Other assets non-current and current
Other Assets Non Current And Current Recognised As Of Acquisition Date
Cash and cash equivalents
Cash And Cash Equivalents Recognised As Of Acquisition Date
Total Assets
Assets Recognized As Of Acquisition Date
Liabilities
Liabilities [Abstract]
Provisions non-current and current
Provisions Non Current And Current Recognised As Of Acquisition Date
Trade payables
Trade Payables Recognised As Of Acquisition Date
Other liabilities non-current and current
Other Liabilities Non Current And Current Recognised As Of Acquisition Date
Total liabilities
Liabilities Recognized As Of Acquisition Date
Total identifiable net assets at fair value
Identifiable Assets Acquired Liabilities Assumed
Consideration transferred
Identifiable Assets Acquired Liabilities Assumed And Goodwill
Bargain purchase
Bargain Purchase Gain On Acquisition
Consideration transferred
Identifiable Assets Acquired Liabilities Assumed And Goodwill Net Of Bargain Purchase
Consideration
Acquisitiondate Fair Value Of Total Consideration Transferred [Abstract]
Shares issued, at fair value
Shares Issued At Fair Value
Cash paid
Contingent consideration liability
Total consideration
Acquisitiondate Fair Value Of Total Consideration Transferred
Operating loss
Revenues
Transaction costs
Acquisitionrelated Costs Recognised As Expense For Transaction Recognised Separately From Acquisition Of Assets And Assumption Of Liabilities In Business Combination
Business combination maximum potential contingent cash consideration.
Contingent cash consideration
Business Combination Contingent Cash Consideration
Consideration transferred.
American depositary shares.
Aggregate value of merger consideration
Consideration Transferred
American depositary shares
American Depositary Shares
Intangible assets, number of neoantigen targeted therapies under development.
Intangible assets, number of neoantigen targeted therapies under development
Intangible Assets Number Of Neoantigen Targeted Therapies Under Development
Deferred tax liabilities recognized
Deferred Tax Liabilities Recognised As Of Acquisition Date
Bargain purchase
As of January 1, 2020
Goodwill
Acquisition of subsidiaries and businesses
Additional Recognition Goodwill
Currency differences
Increase Decrease Through Net Exchange Differences Goodwill
As of December 31, 2020
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Abstract]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table]
Major customers [axis]
Major Customers [Axis]
Customers [member]
Major Customers [Member]
Pfizer Inc.
Pfizer Inc.
Pfizer Inc [Member]
Genentech Inc.
Genentech Inc
Genentech Inc [Member]
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd
Shanghai Fosun Pharmaceutical Group Co Ltd [Member]
Other.
Other
Other [Member]
COVID-19 vaccine revenues.
COVID-19 Vaccine Revenues
C O V I D19 Vaccine Revenues [Member]
Sales to collaboration partner.
Sales To Collaboration Partner
Sales To Collaboration Partner [Member]
Direct product sales to BioNTech customers.
Direct Product Sales to BioNTech Customers
Direct Product Sales To Bio N Tech Customers [Member]
Share of collaboration partners gross profit.
Share Of Collaboration Partners Gross Profit
Share Of Collaboration Partners Gross Profit [Member]
Other sales.
Other Sales
Other Sales [Member]
Performance obligations [axis]
Performance Obligations [Axis]
Performance obligations [member]
Performance Obligations [Member]
Goods and Services Transferred at a Point in Time
Performance Obligations Satisfied At Point In Time [Member]
Goods and Services Transferred Over Time
Performance Obligations Satisfied Over Time [Member]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenues from contracts with customers
Number of customers.
Sanofi S.A.
Sanofi S.A.
Sanofi S A [Member]
Fosun Pharma.
Fosun Pharma
Fosun Pharma [Member]
Intangible assets with indefinite useful life [axis]
Intangible Assets With Indefinite Useful Life [Axis]
Intangible assets with indefinite useful life [member]
Intangible Assets With Indefinite Useful Life [Member]
Cellscript sublicense.
Cellscript Sublicense
Cellscript Sublicense [Member]
Revenues from selling drug product batches to Pfizers manufacturing site.
Revenues from Selling Drug Product Batches to Pfizer's Manufacturing Site
Revenues From Selling Drug Product Batches To Pfizers Manufacturing Site [Member]
Geographical
Statement Geographical [Axis]
Geographical
Segment Geographical [Domain]
Revenue from share of collaboration partner's gross profit.
Revenue from Share of Collaboration Partner's Gross Profit
Revenue From Share Of Collaboration Partners Gross Profit [Member]
Other sales transactions.
Other Sales Transactions
Other Sales Transactions [Member]
Bill-and-hold Transaction [Member]
Bill and Hold Transaction
Bill And Hold Transaction [Member]
Number of customers
Number Of Customers
Percentage of revenue
Percentage Of Entitys Revenue
Non refundable upfront cash payment.
Revenue from collaboration.
Revenue from collaboration
Revenue From Collaboration
Non refundable upfront cash payment
Non Refundable Upfront Cash Payment
Milestone payment recognized as revenue.
Milestone payment recognized as revenue
Milestone Payment Recognized As Revenue
Revenues derived from deferred upfront payments.
Revenues derived from deferred upfront payments
Revenues Derived From Deferred Upfront Payments
Percentage of reimbursement of sublicense costs.
Sublicense agreement date.
Percentage of reimbursement of sublicense costs
Percentage Of Reimbursement Of Sublicense Costs
Sublicense agreement date
Sublicense Agreement Date
Conditional marketing authorization countries.
Conditional marketing authorization countries
Conditional Marketing Authorization Countries
Contract liabilities
Contract Liabilities
Trade receivable maturity period.
Trade receivable maturity period
Trade Receivable Maturity Period
Remaining upfront fees contract liabilities.
Advance payment received for future COVID 19 vaccine sale.
Remaining upfront fees contract liabilities
Remaining Upfront Fees Contract Liabilities
Advance payment received for future COVID 19 vaccine sale
Advance Payment Received For Future C O V I D19 Vaccine Sale
Advance payments received on other sales
Current Advances
Revenue recognized included in contract liabilities at the beginning of the year.
Amounts included in contract liabilities at the beginning of the year
Deferred Revenue Recognized Included Contract Liabilities
Disclosure Of Performance Obligations [Abstract]
Disclosure Of Performance Obligations [Table]
Disclosure Of Performance Obligations [Table]
Maturity [axis]
Maturity [Axis]
Aggregated time bands [member]
Aggregated Time Bands [Member]
Within One Year
Not Later Than One Year [Member]
More Than One Year
Later Than One Year [Member]
Unsatisfied or partially unsatisfied.
Unsatisfied Or Partially Unsatisfied
Unsatisfied Or Partially Unsatisfied [Member]
Disclosure Of Performance Obligations [Line Items]
Disclosure Of Performance Obligations [Line Items]
Line items representing income and expenses.
Schedule of Income and expenses.
Disclosure Of Income And Expenses [Table]
Disclosure Of Income And Expenses [Table]
Disclosure Of Income And Expenses [Line Items]
Disclosure Of Income And Expenses [Line Items]
Costs of sales
Axis representing income and expenses by nature.
Income And Expenses By Nature
Income And Expenses By Nature [Axis]
Income and expense by nature.
Income And Expenses By Nature Member
Income And Expenses By Nature [Member]
Wages, benefits and social security expense.
Wages, Benefits and Social Security Expense
Wages Benefits And Social Security Expense [Member]
Laboratory supplies.
Laboratory Supplies
Laboratory Supplies [Member]
Purchased Services.
Purchased Services
Purchased Services [Member]
Lease and lease related cost.
Lease and Lease Related Cost
Lease And Lease Related Cost [Member]
Other income expense.
Other
Other Income Expense [Member]
IT costs.
IT Costs
I T Costs [Member]
Transport costs.
Transport Costs
Transport Costs [Member]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying Amount Accumulated Depreciation Amortisation And Impairment And Gross Carrying Amount [Axis]
Carrying amount [member]
Carrying Amount [Member]
Depreciation and Amortization
Accumulated Depreciation And Amortisation [Member]
Research and development expenses
Nature of expenses.
Nature Of Expenses
Nature Of Expenses [Axis]
Nature of expenses.
Nature Of Expenses Member
Nature Of Expenses [Member]
General and administrative expenses.
General And Administrative Expenses
General And Administrative Expenses [Member]
Government grant.
Grant by Bundesministerium fuer Bildung und Forschung (BMBF)
Government Grants [Member]
Sales and marketing expenses
IT and Office Equipment
Office Equipment [Member]
Insurance premiums.
Insurance Premiums
Insurance Premiums [Member]
Research services.
Research Services
Research Services [Member]
Job advertisement expenses.
Job Advertisement Expenses
Job Advertisement Expenses [Member]
Contract staffing.
Contract Staffing
Contract Staffing [Member]
General and administrative expenses
Charge in connection with certain withholding tax payments for intellectual property licenses.
Charge in connection with certain withholding tax payments for intellectual property licenses
Charge In Connection With Certain Withholding Tax Payments For Intellectual Property Licenses
Government Grants
Bargain purchase.
Bargain Purchase
Bargain Purchase [Member]
Government grant
Government grants received.
Government grants.
Government Grants [Abstract]
Government Grants [Abstract]
As of January 1
Government Grants
Received during the year
Government Grants Received
Released to the consolidated statements of operations
Revenue From Government Grants
As of December 31
Total non-current
Noncurrent Government Grants
Interest income
Revenue From Interest
Foreign exchange gains, net
Net Foreign Exchange Gain
Total
Foreign exchange gains
Amortization of financial instruments.
Fair value adjustments of financial instruments measured at fair value.
Amortization of financial instruments
Amortization Of Financial Instruments
Fair value adjustments of financial instruments measured at fair value
Fair Value Adjustments Of Financial Instruments Measured At Fair Value
Foreign exchange loss, net
Net Foreign Exchange Loss
Total
Foreign exchange losses
Expenses arising from fair value measurement adjustments of derivative embedded within convertible note
Wages and salaries
Wages And Salaries
Social security costs
Social Security Contributions
Pension costs
Postemployment Benefit Expense Defined Benefit Plans
Total
Employee Benefits Expense
Corporate income tax rate during the reporting period.
Solidarity surcharge rate.
Change in average trade tax rate.
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Abstract]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table]
Temporary difference, unused tax losses and unused tax credits [axis]
Temporary Difference Unused Tax Losses And Unused Tax Credits [Axis]
Temporary difference, unused tax losses and unused tax credits [member]
Temporary Difference Unused Tax Losses And Unused Tax Credits [Member]
German Tax Group.
German Tax Group
German Tax Group [Member]
German entities not within tax group.
German Entities Not Within Tax Group
German Entities Not Within Tax Group [Member]
U.S. tax group.
U.S. Tax Group
United States Tax Group [Member]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items]
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items]
Corporate income tax rate
Corporate Income Tax Rate
Solidarity surcharge rate
Solidarity Surcharge Rate
Change in average trade tax rate
Change In Average Trade Tax Rate
Statutory tax rate
Applicable Tax Rate
State income tax with average rate
Average Effective Tax Rate
Current income taxes
Current Tax Expense Income
Deferred taxes
Deferred Tax Expense Income
Other taxes
Other Components Of Tax Expense Income
Income taxes
Disclosure of major components of tax expense income.
Disclosure of major components of tax expense income table.
Disclosure Of Major Components Of Tax Expense Income [Table]
Disclosure Of Major Components Of Tax Expense Income [Table]
Tax Losses
Unused Tax Losses [Member]
Temporary Differences
Temporary Difference [Member]
Disclosure Of Major Components Of Tax Expense Income [Line Items]
Disclosure Of Major Components Of Tax Expense Income [Line Items]
Expected tax benefit (based on BioNTech`s statutory tax rate of 30.79%, 2019: 30.78%, 2018: 30.99%)
Tax Expense Income At Applicable Tax Rate
Effects
Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates [Abstract]
Government grants exempted from taxes
Government Grants Exempted From Taxes
Non-deductible expenses
Tax Effect Of Expense Not Deductible In Determining Taxable Profit Tax Loss
Add-back for trade tax purposes
Add Back For Trade Tax Purposes
Non-tax effective bargain purchase
Non Tax Effective Bargain Purchase
Non-recognition of tax effect on share-based payment expenses
Non Recognition Of Tax Effect On Share Based Payment Expenses
Tax-effective equity transaction costs
Tax Effective Equity Transaction Costs
Utilization of tax losses
Tax Effect Of Tax Losses
Non-recognition of deferred taxes on tax losses and temporary differences
Tax Effect Of Nonrecognition Of Deferred Taxes On Tax Losses And Temporary Differences
Recognition of deferred taxes not recognized in prior periods
Tax Benefit Arising From Previously Unrecognised Tax Loss Tax Credit Or Temporary Difference Of Prior Period Used To Reduce Deferred Tax Expense
Effect from lower foreign income tax rate
Tax Effect Of Foreign Tax Rates
Adjustment prior year tax
Adjustments For Current Tax Of Prior Period
Tax credit
Tax Effect Of Tax Credit
Other effects
Other Tax Effects For Reconciliation Between Accounting Profit And Tax Expense Income
Income taxes
Deferred tax expense income recognised in other comprehensive income.
Net Deferred Tax Assets And Liabilities [Abstract]
Gross Carrying Amount
Gross Carrying Amount [Member]
Valuation adjustment.
Valuation Adjustment
Valuation Adjustment [Member]
Fixed assets.
Fixed assets
Fixed Assets [Member]
Inventory.
Inventories
Inventory [Member]
Leases.
Leases
Leases [Member]
Contract liabilities.
Contract liabilities
Contract Liabilities [Member]
Interest bearing loans and borrowings.
Interest-bearing loans and borrowings
Interest Bearing Loans And Borrowings [Member]
Provisions.
Provisions
Provisions [Member]
Net employee defined benefit liabilities
Net Defined Benefit Liability Asset [Member]
Other deferred taxes.
Other (incl. deferred expenses)
Other Deferred Taxes [Member]
Tax Loss Carryforward / Tax Credit
Unused Tax Credits [Member]
Deferred tax assets net
Deferred Tax Liability Asset
Recognized in P&L
Deferred Tax Expense Income Recognised In Profit Or Loss
Recognized in OCI
Deferred Tax Expense Income Recognised In Other Comprehensive Income
Acquisition of subsidiaries and businesses
Increase Decrease Through Business Combinations Deferred Tax Liability Asset
Deferred tax assets net
Accumulated tax losses in corporate tax.
Accumulated tax losses in trade tax.
Corporate Tax
Accumulated Tax Losses In Corporate Tax
Trade Tax
Accumulated Tax Losses In Trade Tax
Accumulated tax losses in federal tax credits.
Accumulated tax losses in state tax credits.
Federal Tax Credits
Accumulated Tax Losses In Federal Tax Credits
State Tax Credits
Accumulated Tax Losses In State Tax Credits
Deferred tax assets for unused tax losses recognized.
Corporate income tax losses
Trade tax losses
Deferred tax assets for unused tax losses recognized
Deferred Tax Assets For Unused Tax Losses Recognized
Deferred tax assets and liabilities, net recognized
Federal deferred tax assets operating loss carryforwards expected to expire.
Federal tax losses expiration year.
Federal deferred tax assets operating loss carryforwards not subject to expiration.
State deferred tax assets operating loss carryforwards subject to expiration.
State tax losses expiration year.
Federal tax losses subject to expiration
Federal Deferred Tax Assets Operating Loss Carryforwards Expected To Expire
Federal tax losses expiration year
Federal Tax Losses Expiration Year
Federal tax losses not subject to expiration
Federal Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
State tax losses subject to expiration
State Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
State tax losses expiration year
State Tax Losses Expiration Year
Accumulated federal tax credits
Accumulated state tax credits
Shares issued during period stock split.
Shares issued during period stock split
Shares Issued During Period Stock Split
Gain (loss) attributable to ordinary equity holders of the parent for basic earnings
Weighted average number of ordinary shares for basic EPS
Weighted Average Shares
Effects of dilution from share options
Dilutive Effect Of Share Options On Number Of Ordinary Shares
Weighted average number of ordinary shares adjusted for the effect of dilution
Adjusted Weighted Average Shares
Basic and diluted, profit / (loss) for the period attributable to ordinary equity holders of the parent
Reclassifications property plant and equipment.
Land and Buildings
Land And Buildings [Member]
Construction in progress and advance payments.
Construction in Progress and Advance Payments
Construction In Progress And Advance Payments [Member]
Cumulative Depreciation and Impairment Charges
Accumulated Depreciation Amortisation And Impairment [Member]
Property plant and equipment, Beginning balance
Additions
Additions Other Than Through Business Combinations Property Plant And Equipment
Depreciation
Depreciation Property Plant And Equipment
Disposals
Disposals Property Plant And Equipment
Reclassifications
Reclassifications Property Plant And Equipment
Currency differences
Increase Decrease Through Net Exchange Differences Property Plant And Equipment
Acquisition of subsidiaries and businesses
Acquisitions Through Business Combinations Property Plant And Equipment
Property plant and equipment, Ending balance
Accumulated depreciation amortisation and impairment.
Classes of intangible assets and goodwill [axis]
Classes Of Intangible Assets And Goodwill [Axis]
Intangible assets and goodwill [member]
Intangible Assets And Goodwill [Member]
Goodwill
Goodwill [Member]
Concessions licenses in-process research and development and similar rights.
Concessions, Licenses, in-process R&D and Similar Rights
Concessions Licenses In Process Research And Development And Similar Rights [Member]
Advance payments.
Advance Payments
Advance Payments [Member]
Beginning Balance
Amortization
Accumulated Depreciation Amortisation And Impairment
Additions
Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill
Disposals
Disposals Intangible Assets Other Than Goodwill
Reclassifications
Increase Decrease Through Transfers And Other Changes Intangible Assets Other Than Goodwill
Currency differences
Increase Decrease Through Net Exchange Differences Intangible Assets And Goodwill
Acquisition of subsidiaries and businesses
Acquisitions Through Business Combinations Intangible Assets Other Than Goodwill
Ending Balance
Consolidated structured entities [axis]
Consolidated Structured Entities [Axis]
Entity's total for consolidated structured entities [member]
Entitys Total For Consolidated Structured Entities [Member]
CGU Immunotherapies.
CGU Immunotherapies
C G U Immunotherapies [Member]
External product sales of JPT.
External Product Sales of JPT
External Product Sales Of J P T [Member]
Goodwill
Subsidiaries
Subsidiaries [Member]
United States
Recoverable amount period
Explanation Of Period Over Which Management Has Projected Cash Flows
Discount rate cash flow projection
Description Of Discount Rates Applied To Cash Flow Projections
Growth rate extrapolated
Description Of Discount Rates Used In Current Estimate Of Value In Use
Increase in growth rate cash flow projections.
Increase in discount rate
Increase In Growth Rate Cash Flow Projections
Growth rate
Description Of Growth Rate Used To Extrapolate Cash Flow Projections
Non-current assets
Cash And Cash Equivalents [Abstract]
Total
Disclosure Of Financial Assets [Abstract]
Disclosure Of Financial Assets [Table]
Disclosure Of Financial Assets [Table]
Classes of financial assets [axis]
Classes Of Financial Assets [Axis]
Financial assets, class [member]
Financial Assets [Member]
Trade Receivables
Trade Receivables [Member]
Other financial assets.
Other Financial Assets
Other Financial Assets [Member]
Disclosure Of Financial Assets [Line Items]
Disclosure Of Financial Assets [Line Items]
Financial assets at amortized cost
Financial Assets At Amortised Cost
Total current
Current Financial Assets At Amortised Cost
Total non-current
Noncurrent Financial Assets At Amortised Cost
Derivative, financial liabilities not designated as hedging instruments, at fair value.
Disclosure Of Financial Liabilities [Abstract]
Disclosure Of Financial Liabilities [Table]
Disclosure Of Financial Liabilities [Table]
Classes of financial liabilities [axis]
Classes Of Financial Liabilities [Axis]
Financial liabilities, class [member]
Financial Liabilities [Member]
Borrowings by name [axis]
Borrowings By Name [Axis]
Borrowings by name [member]
Borrowings By Name [Member]
Two point one five percentage secured bank loan.
2.15% Secured Bank Loan
Two Point One Five Percentage Secured Bank Loan [Member]
Two point zero eight percentage secured bank loan.
2.08% Secured Bank Loan
Two Point Zero Eight Percentage Secured Bank Loan [Member]
Convertible note - host contract.
Convertible Note - Host Contract
Convertible Note Host Contract [Member]
Three point five zero percentage secured bank loan.
3.50% Secured Bank Loan
Three Point Five Zero Percentage Secured Bank Loan [Member]
One point nine zero percentage secured bank loan.
1.90% Secured Bank loan
One Point Nine Zero Percentage Secured Bank Loan [Member]
Liabilities arising from financing activities [axis]
Liabilities Arising From Financing Activities [Axis]
Liabilities arising from financing activities [member]
Liabilities Arising From Financing Activities [Member]
Lease Liabilities
Lease Liabilities [Member]
Other financial liabilities, other than interest-bearing loans and borrowings.
Other Financial Liabilities
Other Financial Liabilities Other Than Interest Bearing Loans And Borrowings [Member]
Classes of liabilities [axis]
Classes Of Liabilities [Axis]
Liabilities [member]
Liabilities [Member]
Convertible note - embedded derivative.
Convertible Note - Embedded Derivative
Convertible Note Embedded Derivative [Member]
Contingent Consideration
Contingent Consideration [Member]
Trade payables.
Trade Payables
Trade Payables [Member]
Other financial liabilities.
Other Financial Liabilities
Other Financial Liabilities [Member]
Disclosure Of Financial Liabilities [Line Items]
Disclosure Of Financial Liabilities [Line Items]
Financial liabilities at amortized cost
Financial Liabilities At Amortised Cost
Total current
Current Financial Liabilities At Amortised Cost
Total non-current
Noncurrent Financial Liabilities At Amortised Cost
Financial liabilities maturity date.
Maturity Date
Financial Liabilities Maturity Date
Secured bank loan
Financial Assets Pledged As Collateral For Liabilities Or Contingent Liabilities
Derivatives not designated as hedging instrument
Derivative Financial Liabilities Not Designated As Hedging Instruments At Fair Value
Financial liabilities at fair value through profit or loss
Financial Liabilities At Fair Value Through Profit Or Loss
Total financial liabilities at fair value
Financial Liabilities At Fair Value
Financial liabilities
Financial Liabilities
Total current
Current Financial Liabilities
Total non-current
Noncurrent Financial Liabilities
Number of secured bank loan maintained.
Loan repayable quarterly installment.
Loan repayable quarterly installment commencement date.
Disclosure Of Redesignated Financial Assets And Liabilities [Abstract]
Disclosure Of Redesignated Financial Assets And Liabilities [Table]
Disclosure Of Redesignated Financial Assets And Liabilities [Table]
2.15% secured loan.
2.15% Secured Loan
Two Point One Five Percentage Secured Loan [Member]
2.08% bank loan.
2.08% Bank Loan
Two Point Zero Eight Percentage Bank Loan [Member]
Legal Entity
Legal Entity [Axis]
Entity
Entity [Domain]
Deutsche Bank AG.
Deutsche Bank AG
Deutsche Bank A G [Member]
Types of interest rates [axis]
Types Of Interest Rates [Axis]
Interest rate types [member]
Interest Rate Types [Member]
Cash interest fixed rate.
Cash Interest Fixed Rate
Cash Interest Fixed Rate [Member]
Deferred interest at fixed rate.
Deferred Interest at Fixed Rate
Deferred Interest At Fixed Rate [Member]
European Investment Bank.
EIB Manufacturing Financing
European Investment Bank [Member]
Classes of financial instruments [axis]
Classes Of Financial Instruments [Axis]
Financial instruments, class [member]
Classes Of Financial Instruments [Member]
June twenty twenty private placement.
June 2020 Private Placement
June Twenty Twenty Private Placement [Member]
Convertible note.
Convertible Note
Convertible Note [Member]
Disclosure Of Redesignated Financial Assets And Liabilities [Line Items]
Disclosure Of Redesignated Financial Assets And Liabilities [Line Items]
Number of secured bank loan
Number Of Secured Bank Loan Maintained
Interest rate
Borrowings Interest Rate
Loan repayable quarterly Installment
Loan Repayable Quarterly Installment
Loan repayable quarterly installment commencing date
Loan Repayable Quarterly Installment Commencement Date
Term Loan (Credit A).
Term Loan (Credit B).
Notional amount
Notional Amount
Term loan (Credit A)
Term Loan Credit A
Term loan (Credit B)
Term Loan Credit B
Financial liability, maturity term.
Financial liabilities coupon rate per annum.
Financial liabilities conversion premium percentage above reference price.
Effective interest rate of financial liabilities.
Investment in convertible note
Investment Accounted For Using Equity Method
Maturity period
Financial Liability Maturity Term
Convertible note coupon rate
Financial Liabilities Coupon Rate Per Annum
Conversion premium of convertible note
Financial Liabilities Conversion Premium Percentage Above Reference Price
Effective interest rate
Effective Interest Rate Of Financial Liabilities
Fair value adjustment derived from remeasuring embedded derivative
Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities
The amount of cash on hand and demand deposits denominated in foreign currencies.
Disclosure of cash and cash equivalents.
Disclosure of cash and cash equivalents.
Disclosure Of Cash And Cash Equivalents [Table]
Disclosure Of Cash And Cash Equivalents [Table]
Types of risks [axis]
Types Of Risks [Axis]
Risks [member]
Types Of Risks [Member]
Currency Risk
Currency Risk [Member]
US dollar bank accounts.
US Dollar Bank Accounts
U S Dollar Bank Accounts [Member]
Other Financial Assets in U.S. Dollar
Financial liability.
Financial Liabilities in U.S. Dollar
Financial Liability [Member]
Disclosure Of Cash And Cash Equivalents [Line Items]
Disclosure Of Cash And Cash Equivalents [Line Items]
Total
Cash And Cash Equivalent
Disclosure of effect of changes in foreign exchange rates.
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Abstract]
Disclosure of effect of changes in foreign exchange rates.
Disclosure of effect of changes in foreign exchange rates table.
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]
Currency
Currency [Axis]
All Currencies
All Currencies [Domain]
USD
U S D
Hedging instruments [axis]
Hedging Instruments [Axis]
Hedging instruments [member]
Hedging Instruments [Member]
Positive five percentage change in foreign exchange rate.
+5 %
Positive Five Percentage Change In Foreign Exchange Rate [Member]
Negative five percentage change in foreign exchange rate.
-5%
Negative Five Percentage Change In Foreign Exchange Rate [Member]
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]
Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]
Closing rate
Closing Foreign Exchange Rate
Average rate
Average Foreign Exchange Rate
Foreign currency changes effect on loss before tax.
Foreign currency changes effect on pretax equity.
Effect on loss before tax
Foreign Currency Changes Effect On Loss Before Tax
Effect on pre-tax equity
Foreign Currency Changes Effect On Pretax Equity
1 to 5 Years
Later Than Two Years And Not Later Than Five Years [Member]
More than 5 years
Later Than Five Years [Member]
Liquidity Risk
Liquidity Risk [Member]
Interest bearing loans and borrowings
Interest Bearing Loans And Borrowings
Trade and other payables
Trade And Other Payables
Lease liabilities
Lease Liabilities
Contingent consideration
Contingent Liabilities Recognised In Business Combination
Other financial liabilities
Other Financial Liabilities
Increase (decrease) through reclassification liabilities arising from financing activities.
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Abstract]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table]
Current obligations under lease contracts.
Current Obligations under Lease Contracts
Current Obligations Under Lease Contracts [Member]
Noncurrent obligations under lease contracts.
Non-current Obligations under Lease Contracts
Noncurrent Obligations Under Lease Contracts [Member]
Interest-bearing Loans and Borrowings
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items]
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Line Items]
Beginning balance
Liabilities Arising From Financing Activities
Cash flows
Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
Acquisition of subsidiaries and businesses
Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities
New leases and disposals
Increase Through New Leases Liabilities Arising From Financing Activities
Reclassification
Increase Decrease Through Reclassification Liabilities Arising From Financing Activities
Other
Increase Decrease Through Other Changes Liabilities Arising From Financing Activities
Ending balance
Raw materials and supplies
Current Raw Materials And Current Production Supplies
Unfinished goods
Work In Progress
Finished goods
Finished Goods
Total
Trade And Other Receivables [Abstract]
Prepayments on inventories
Current Prepaid Expenses
Prepayments related to CRO and CMO contracts
Current Advances To Suppliers
Sales tax receivable
Current Receivables From Taxes Other Than Income Tax
Prepayments related to service contracts
Current Prepayments Related To Service Contracts
Other
Other Current Assets Other
Total
Other Assets
Total current
Total non-current
Deferred expense.
Deferred expenses from insurance contracts
Deferred Expenses From Insurance Contracts
Deferred expenses from CRO and CMO contracts
Deferred Expenses From Contract Manufacturing And Contract Research Organizations
Other
Other Deferred Expenses
Total
Deferred Expense
Total non-current
Deferred Expense Non Current
Disclosure Of Classes Of Share Capital [Table]
Disclosure Of Classes Of Share Capital [Table]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
Shanghai Fosun Pharmaceuticals (Group) Co., Ltd
Neon Therapeutics Inc.
Neon Therapeutics, Inc.
Neon Therapeutics Inc [Member]
Capital requirements [axis]
Capital Requirements [Axis]
Capital requirements [member]
Capital Requirements [Member]
Global offering.
Global Offering
Global Offering [Member]
June 2020 private placement.
June 2020 Private Placement
June2020 Private Placement [Member]
At-the-market offering program.
At-The-Market Offering Program
At Market Offering Program [Member]
Ordinary shares series B.
Ordinary Shares Series B
Ordinary Shares Series B [Member]
HONG KONG
HONG KONG
Associates [axis]
Significant Investments In Associates [Axis]
Entity's total for associates [member]
Entitys Total For Associates [Member]
Bill & Me linda Gates Foundation.
Bill & Melinda Gates Foundation
Bill And Me Linda Gates Foundation [Member]
Initial public offering.
Initial Public Offering (IPO)
Initial Public Offering [Member]
Disclosure Of Classes Of Share Capital [Line Items]
Disclosure Of Classes Of Share Capital [Line Items]
Issuance of share capital
Issue Of Equity
Nominal value
Par Value Per Share
Equity transaction costs
Number of ordinary shares issuable.
Aggregate proceeds from issuance of ordinary share
Proceeds From Issue Of Ordinary Shares
Number of ordinary shares issuable
Number Of Ordinary Shares Issuable
Shares issued
Number Of Shares Issued
Percentage of American depository shares to ordinary shares.
Shares issued price per share 1.
Percentage of ADS to ordinary shares
Percentage Of American Depository Shares To Ordinary Shares
Ordinary shares issued price per share
Shares Issued Price Per Share1
Equity issuable.
Equity issuable
Equity Issuable
Maximum proceeds receivable from issuance of ordinary shares.
Maximum gross proceeds receivable from issuance of ordinary shares
Maximum Proceeds Receivable From Issuance Of Ordinary Shares
Cash investment.
Cash investment
Cash Investment
Acquisition of non-controlling interest.
Derecognition of non controlling interest.
Decrease in capital reserve.
Remaining non-controlling interests acquired
Remaining Noncontrolling Interests Acquired Percentage
Derecognition of non-controlling interest
Derecognition Of Non Controlling Interest
Decrease in capital reserve
Decrease In Capital Reserve
Ordinary shares issued
Number Of Shares Issued And Fully Paid
Ordinary shares issued but not fully paid
Number Of Shares Issued But Not Fully Paid
Increase in share capital
Changes In Equity
Option vesting period.
Percentage of other equity instrument non vesting rate.
Two thousand twenty restricted stock unit plan.
2020 Restricted Stock Unit Plan
Two Thousand Twenty Restricted Stock Unit Plan [Member]
Employee equity plan long term incentive program.
LTI Program
Employee Equity Plan Long Term Incentive Program [Member]
Employee equity plan long term incentive-plus program.
LTI-plus Program
Employee Equity Plan Long Term Incentive Plus Program [Member]
Research and development expenses.
Research and Development Expenses
Research And Development Expenses [Member]
Title of Individual
Title Of Individual [Axis]
Title of Individual
Title Of Individual With Relationship To Entity [Domain]
Prof. Ugur Sahin, M.D.
Prof. Ugur Sahin, M.D.
Professor Ugur Sahin M D [Member]
Sean Marett.
Sean Marett
Sean Marett [Member]
Dr. Sierk Poetting.
Dr. Sierk Poetting
Dr Sierk Poetting [Member]
Dr. Ozlem Tureci.
Dr. Ozlem Tureci
Dr Ozlem Tureci [Member]
Ryan Richardson.
Ryan Richardson
Ryan Richardson [Member]
Ordinary Shares
Ordinary Shares [Member]
Maximum
Maximum [Member]
Share-based payment expenses
Expense From Sharebased Payment Transactions With Employees
Option rights vesting term
Description Of Vesting Requirements For Sharebased Payment Arrangement
Option rights vesting period
Option Vesting Period
Percentage of non-vesting rate
Percentage Of Other Equity Instrument Non Vesting Rate
Number of instruments other equity instruments expected to be allocated.
Beginning Balance, Restricted Stock Units
Number Of Other Equity Instruments Outstanding In Sharebased Payment Arrangement
Expected to be allocated, Restricted Stock Units
Number Of Instruments Other Equity Instruments Expected To Be Allocated
Ending Balance, Restricted Stock Units
Weighted average exercise price of other equity instruments expected to be allocated in share based payment arrangement.
Beginning Balance, Share price
Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Sharebased Payment Arrangement2019
Expected to be allocated, Share price
Weighted Average Exercise Price Of Other Equity Instruments Expected To Be Allocated In Sharebased Payment Arrangement
Ending Balance, Share price
Expense From Sharebased Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets [Abstract]
Cost of sales1.
Cost of Sales
Cost Of Sales1 [Member]
Sales and marketing expenses.
Sales and Marketing Expenses
Sales And Marketing Expenses [Member]
Expense recognized for employee services received
Cash settled expense from share based payment transactions with employees.
Share-based payment expenses
Cash Settled Expense From Sharebased Payment Transactions With Employees
Increase (decrease) in share based payment value.
Grant of options, base value
Expected Dividend Share Options Granted
Increase (decrease) in grant of options, base value, for the year 2022
Increase Decrease In Share Based Payment Value
Number of share options expected to be allocated in share based payment arrangement year one.
Number of share options expected to be allocated in share based payment arrangement year two.
Beginning Balance, Share options
Number Of Outstanding Share Options
Granted, share options
Number Of Share Options Granted In Sharebased Payment Arrangement
Expected to be allocated as of estimated allocation date 2021, share options
Number Of Share Options Expected To Be Allocated In Share Based Payment Arrangement Year One
Expected to be allocated as of estimated allocation date 2022, share options
Number Of Share Options Expected To Be Allocated In Share Based Payment Arrangement Year Two
Forfeited, share options
Number Of Share Options Forfeited In Sharebased Payment Arrangement
Ending Balance, Share options
Weighted average exercise price of share options expected to be allocated in share based payment arrangement year one.
Weighted average exercise price of share options expected to be allocated in share based payment arrangement year two.
Beginning Balance, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Outstanding In Sharebased Payment Arrangement2019
Granted, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Granted In Sharebased Payment Arrangement2019
Expected to be allocated as of estimated allocation date 2021, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Expected To Be Allocated In Share Based Payment Arrangement Year One
Expected to be allocated as of estimated allocation date 2022, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Expected To Be Allocated In Share Based Payment Arrangement Year Two
Forfeited, Weighted-average exercise price
Weighted Average Exercise Price Of Share Options Forfeited In Sharebased Payment Arrangement2019
Ending Balance, Weighted-average exercise price
Input parameter for performance criterion 1 - Threshold Amount.
Input parameter capitalization for performance criterion 2 - Target Price.
Input parameter increase factor for performance criterion 2 - Target Price.
Option expiration period.
Percentage of exercise price increase
Percentage Of Increase In Exercise Price
Threshold amount of dividend by number of shares outstanding immediately following initial public offering
Threshold Amount Of Dividend By Number Of Shares Outstanding Immediately Following Initial Public Offering
Percentage of target share price applicable for prior twelve month period
Percentage Of Target Share Price Applicable For Prior Twelve Month
Option rights expiration period
Option Expiration Period
Non-adjusting events after reporting period [axis]
Nonadjusting Events After Reporting Period [Axis]
Non-adjusting events after reporting period [member]
Nonadjusting Events [Member]
Estimated allocation date one.
Estimated Allocation Date 2021
Estimated Allocation Date One [Member]
Estimated allocation date two.
Estimated Allocation Date 2022
Estimated Allocation Date Two [Member]
Weighted average fair value
Weighted Average Fair Value At Measurement Date Share Options Granted
Weighted average share price
Weighted Average Share Price Share Options Granted2019
Exercise price
Exercise Price Share Options Granted2019
Expected volatility (%)
Description Of Expected Volatility Share Options Granted
Expected life (years)
Description Of Option Life Share Options Granted
Risk-free interest rate (%)
Description Of Risk Free Interest Rate Share Options Granted
Dr. Ozlem Tureci, M.D.
Dr. Ozlem Tureci, M.D.
Dr Ozlem Tureci M D [Member]
Share options outstanding
Weighted-average exercise price
Weighted average remaining contractual life of share options allocated and expected to be allocated.
Options allocated and expected to be allocated, weighted-average expected life
Weighted Average Remaining Contractual Life Of Share Options Allocated And Expected To Be Allocated
The option rights can be exercised at the latest eight years after the allocation date. If they have not been exercised by that date, they will forfeit without compensation.
Exercise price currency translation of public offering price per share.
Option to purchase ordinary shares
Number Of Instruments Granted In Sharebased Payment Arrangement
Exercise price in translation for IPO
Exercise Price Currency Translation Of Public Offering Price Per Share
Option rights exercisable period
Option Exercisable Period
Granted, share options
Forfeited, share options
Options outstanding, weighted-average expected life
Weighted Average Remaining Contractual Life Of Outstanding Share Options2019
Number of ordinary shares underlying options granted in sharebased payment arrangement.
Number of ordinary shares underlying options forfeited in sharebased payment arrangement.
Number of ordinary shares underlying options outstanding.
Beginning Balance, Number of Ordinary Shares underlying options
Number Of Ordinary Shares Underlying Options Outstanding
Granted, Shares underlying options
Number Of Ordinary Shares Underlying Options Granted In Sharebased Payment Arrangement
Forfeited, Shares underlying options
Number Of Ordinary Shares Underlying Options Forfeited In Sharebased Payment Arrangement
Ending Balance, Number of Ordinary Shares underlying options
Number of ordinary shares underlying options
Liabilities to employees
Current Liabilities For Employees Benefits
Other
Other Liabilities Other
Total
Other Liabilities
Disclosure Of Quantitative Information About Rightofuse Assets [Abstract]
Advance payments related to embedded leases.
Additions to right-of-use assets
Additions To Rightofuse Assets
Advance payments related to embedded leases
Advance Payments Related To Embedded Leases
Lease liabilities
Lease Liabilities [Abstract]
Current
Current Lease Liabilities
Non-current
Noncurrent Lease Liabilities
Total
Future lease payments for non-cancellable lease contracts
Gross Lease Liabilities
Lease expenses recognized in profit or loss.
Depreciation charge
Depreciation Rightofuse Assets
Interest on lease liabilities
Expense related to short-term leases (included in other expenses)
Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Expense relating to leases of low-value assets that are not short-term leases (included in other expenses)
Expense Relating To Leases Of Lowvalue Assets For Which Recognition Exemption Has Been Used
Total amounts recognized in profit or loss
Lease Expenses Recognized In Profit Or Loss
Total cash outflow for leases
Cash Outflow For Leases
Undiscounted future lease payments related to renewal options not included in lease liabilities.
Undiscounted potential future lease payments related to renewal options not included in lease liabilities until 2049
Undiscounted Future Lease Payments Related To Renewal Options Not Included In Lease Liabilities
Percentage of defined contribution plan of salary.
Maximum pension fund contributions.
pension fund contributions expected for the following financial year.
Annual pension entitlement of employee contribution.
Disclosure Of Defined Benefit Plans [Table]
Disclosure Of Defined Benefit Plans [Table]
Characteristics of defined benefit plans [axis]
Characteristics Of Defined Benefit Plans [Axis]
Characteristics of defined benefit plans [member]
Characteristics Of Defined Benefit Plans [Member]
Final Salary Defined Benefit Pension Plan
Final Salary Pension Defined Benefit Plans [Member]
Funding arrangements of defined benefit plans [axis]
Funding Arrangements Of Defined Benefit Plans [Axis]
Funding arrangements of defined benefit plans [member]
Funding Arrangements Of Defined Benefit Plans [Member]
Funded Base Plan
Wholly Or Partly Funded Defined Benefit Plans [Member]
Non-funded Supplement Plan
Wholly Unfunded Defined Benefit Plans [Member]
Disclosure Of Defined Benefit Plans [Line Items]
Disclosure Of Defined Benefit Plans [Line Items]
Description of participants contribute to retirement benefit plan
Explanation Of Whether Participants Contribute To Retirement Benefit Plan
Percentage of defined contribution plan of salary
Percentage Of Defined Contribution Plan Of Salary
Annual pension entitlement of employee contribution for one Euro
Annual Pension Entitlement Of Employee Contribution
Maximum pension fund contributions
Maximum Pension Fund Contributions
Pension fund contributions expected for the following financial year
Pension Fund Contributions Expected For Following Financial Year
Defined benefit plans [axis]
Defined Benefit Plans [Axis]
Defined benefit plans [member]
Defined Benefit Plans [Member]
Base plan.
Base Plan
Base Plan [Member]
Supplement plan.
Supplement Plan
Supplement Plan [Member]
Defined benefit obligation recognized in non-current provisions
Noncurrent Provisions For Employee Benefits
Service cost
Current Service Cost Net Defined Benefit Liability Asset
Net interest expense
Interest Expense Income Net Defined Benefit Liability Asset
Total
Increase Decrease In Net Defined Benefit Liability Asset
Actuarial changes arising from changes in financial assumptions
Actuarial Gains Losses Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset
Experience adjustments
Actuarial Gains Losses Arising From Experience Adjustments Net Defined Benefit Liability Asset
Total
Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset
As of January 1, 2020
Liability Asset Of Defined Benefit Plans
Acquisition of subsidiaries and businesses
Increase Decrease Through Business Combinations And Disposals Net Defined Benefit Liability Asset
Service cost
Net interest expense
Benefits paid
Benefits Paid Or Payable
Actuarial changes arising from changes in financial assumptions
Experience adjustments
As of December 31, 2020
Discount rate
Actuarial Assumption Of Discount Rates
Price inflation
Actuarial Assumption Of Expected Rates Of Inflation
Rate of salary increase
Actuarial Assumption Of Expected Rates Of Salary Increases
Pension increases for in-payment benefits
Actuarial Assumption Of Expected Rates Of Pension Increases
Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Abstract]
Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Table]
Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Table]
Actuarial assumptions [axis]
Actuarial Assumptions [Axis]
Actuarial assumptions [member]
Actuarial Assumptions [Member]
Discount Rate
Actuarial Assumption Of Discount Rates [Member]
Pension Increases (Decreases)
Actuarial Assumption Of Expected Rates Of Pension Increases [Member]
Defined benefit obligation due to reasonably possible increase in actuarial assumption
Increase Decrease In Defined Benefit Obligation Due To Reasonably Possible Increase In Actuarial Assumption
Defined benefit obligation due to reasonably possible decrease in actuarial assumption
Increase Decrease In Defined Benefit Obligation Due To Reasonably Possible Decrease In Actuarial Assumption
Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]
Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]
Percentage of reasonably possible increase in actuarial assumption
Percentage Of Reasonably Possible Increase In Actuarial Assumption
Percentage of reasonably possible decrease in actuarial assumption
Percentage Of Reasonably Possible Decrease In Actuarial Assumption
Weighted average duration of defined benefit obligation
Weighted Average Duration Of Defined Benefit Obligation2019
1 to 5 Years
Later Than One Year And Not Later Than Five Years [Member]
Expected payments or contributions in future years
Estimate Of Contributions Expected To Be Paid To Plan
Key management personnel compensation, short term employee benefits accrued.
Short-term employee benefits incurred
Key Management Personnel Compensation Shortterm Employee Benefits
Short-term employee benefits accrued*
Key Management Personnel Compensation Short Term Employee Benefits Accrued
Share-based payments
Key Management Personnel Compensation Sharebased Payment
Total compensation paid to key management personnel
Key Management Personnel Compensation
Key management personnel compensation share based payment ordinary shares.
Share-based payment, ordinary shares
Key Management Personnel Compensation Share Based Payment Ordinary Shares
Disclosure Of Transactions Between Related Parties [Table]
Disclosure Of Transactions Between Related Parties [Table]
Cofounder and chief executive officer.
Co-founder and Chief Executive Officer
Cofounder And Chief Executive Officer [Member]
Disclosure Of Transactions Between Related Parties [Line Items]
Disclosure Of Transactions Between Related Parties [Line Items]
Granted shares
Consulting services and patent assignment.
Purchases of goods and service related party transactions.
Goods and services from related party transactions.
Key Management Personnel of Entity or Parent
Key Management Personnel Of Entity Or Parent [Member]
Consulting services / patent assignment
Consulting Services And Patent Assignment
Purchases of various goods and services from TRON
Purchases Of Goods And Service Related Party Transactions
Total
Goods And Services From Related Party Transactions
Consulting service provider.
Consulting Service Provider
Consulting Service Provider [Member]
TRON.
TRON
T R O N [Member]
Outstanding balances
Amounts Payable Related Party Transactions
Purchases from related party transactions.
Other Related Parties
Other Related Parties [Member]
Purchases of various goods and services from entities controlled by ATHOS KG
Purchases of property and other assets from entities controlled by ATHOS KG
Purchases Of Property And Other Assets Related Party Transactions
Total
Purchases From Related Party Transactions
ATHOSKG.
ATHOS KG
A T H O S K G [Member]
Outstanding balances of related party transaction
Provisions For Doubtful Debts Related To Outstanding Balances Of Related Party Transaction
Bad debt expense has been recognized
Expense Recognised During Period For Bad And Doubtful Debts For Related Party Transaction
Number of additional doses to be supplied.
Aggregate number of doses to be supplied.
Number of European Union member states.
Option to request supply of number of additional doses.
Disclosure of events after reporting period.
Disclosure of events after reporting period.
Disclosure Of Events After Reporting Period [Table]
Disclosure Of Events After Reporting Period [Table]
Supply of COVID-19 vaccine.
Supply Of COVID-19 Vaccine
Supply Of C O V I D19 Vaccine [Member]
Counterparties [axis]
Counterparties [Axis]
Counterparties [member]
Counterparties [Member]
United States government.
U.S. Government
United States Government [Member]
European Union member states.
European Union Member States
European Union Member States [Member]
Disclosure Of Events After Reporting Period [Line Items]
Disclosure Of Events After Reporting Period [Line Items]
Number of additional doses of COVID-19 vaccine to be supplied
Number Of Additional Doses To Be Supplied
Total number of doses of COVID-19 vaccine to be supplied
Aggregate Number Of Doses To Be Supplied
Number of European Union member states.
Number Of European Union Member States
Option to request supply of number of additional doses of COVID-19 vaccine
Option To Request Supply Of Number Of Additional Doses